October 20th - Breakout Workshop: Optimizing Medication Information

The quality of health information can affect patient understanding and activation which, in turn, can greatly affect trial recruitment and participation as well as the safe and appropriate use of treatments. There is increasing interest throughout the healthcare industry in optimizing and evaluating information by leveraging both existing internal and external methods and expertise. Industry trends and focus on patient centricity have led to an increase in the development of patient-facing content for general use and regulatory submission.

In this workshop you will learn how to develop a consistent approach to optimizing medication information that objectively assesses these documents following evidence-based health literacy best practices. You will be walked through these recommendations in a step by step process with an industry use case. In addition, you will lean how to optimize information about medication and treatment to improve understandability and actionability while supporting adherence to company guidance on best practices involving patients, healthcare providers and subject matter experts.

Annlouise Assaf

Senior Director, Patient Health Activation Expert with the Global Medical Impact Assessment (GMIA) team within Worldwide Medical and Safety at Pfizer

Annlouise Assaf, Ph.D. is a pharmacoepidemiologist who is a Senior Director, Patient Health Activation Expert with the Global Medical Impact Assessment (GMIA) team within Worldwide Medical and Safety at Pfizer. In Dr. Assaf's role in the Chief Medical Office, she focuses on quality benefit-risk communication, improving patient health activation and equity, and optimizing patient-facing health content so that patients can make informed shared decisions about their treatment with their healthcare providers, use their medications safely and appropriately, and improve value outcomes. Prior to joining Pfizer, she spent many years in academic medicine and clinical research.  She received her doctorate from Roswell Park Cancer Institute at the State University of New York at Buffalo, is currently a Professor (Adjunct) at Brown University School of Public Health and the preceptor for the Pfizer-Brown University Pre-doctoral Fellowship.

Stacy C. Bailey

Dr. Bailey is a health services researcher investigating the definition and measurement of health literacy, its extent and associations with various health outcomes, and the testing of innovative and viable ‘low-literacy’ intervention strategies to help individuals promote, protect, and manage their health. Her work also focuses on the broader theme of health inequalities, especially those experienced by individuals with limited English proficiency.

Candida Halton

University of Westminster, London, UK

Candida is a healthcare communications specialist and visiting lecturer / researcher in health psychology at University of Westminster, London, UK. She is the founder of Studio Health, a London-based practice that works with clients to optimize patient-HCP communications. Candida and her team work with health professional groups, the pharmaceutical industry and communications consultancies.

Joanna Lem

Director, Safety Surveillance Research Strategic Implementation Lead, Pfizer, Inc.

Asia (Joanna) Lem, MPH is a Director, Safety Surveillance Research Strategic Implementation Lead at Pfizer, Inc.. She has been with Pfizer’s Safety Surveillance Research Group (formerly known as Safety Epidemiology group) since 2007.  Asia has a Master in Public Health (MPH) degree from the Yale School of Public Health. In the past few years, her work experience and focus had been in the area of design and implementation of evaluations of risk minimization programs; she is also interested how health communication and health literacy best practices relate to the program effectiveness.

Michael Wolf

James R. Webster Jr. Professor, Medicine within the Feinberg School of Medicine at Northwestern University

Dr. Michael Wolf is the James R. Webster Jr. Professor of Medicine within the Feinberg School of Medicine at Northwestern University. In addition, Dr. Wolf serves as Director for the Center for Applied Health Research on Aging (CAHRA) and leads Northwestern’s Claude D. Pepper Older Americans Independence Center – a member of the National Institute on Aging’s Pepper Center Network. He is health services researcher and cognitive-behavioral scientist with expertise in health literacy, aging, chronic disease self-management, and the design of health system interventions to promote health, particularly among more medically complex, older adults living with multiple chronic conditions (MCC). For the past two decades, Dr. Wolf has led studies investigating: 1) individual and health system determinants of health services use and outcomes, and 2) the effectiveness and fidelity of interventions aimed at helping patients better engage in healthcare and self-manage chronic conditions. In 2004, Dr. Wolf founded the Health Literacy & Learning Program (HeLP) at Northwestern to create a network of multidisciplinary faculty that could partner together to generate applied, innovative research that would help transform the delivery of healthcare for vulnerable patients (older adults a specific target). He also serves as Associate Division Chief for General Internal Medicine & Geriatrics, and Associate Vice Chair for the Department of Medicine

Lori Henault (Moderator)

Key:

Complete
Failed
Available
Locked
October 20th: Workshop: Optimizing Medication Information
Recorded 10/20/2020
Recorded 10/20/2020 Annlouise Assaf Pfizer / Brown University Candida Halton Studio Health Michael Wolf Northwestern University Stacy C. Bailey Northwestern University Joanna Lem Pfizer Description: The quality of health information can affect patient understanding and activation which, in turn, can greatly affect trial recruitment and participation as well as the safe and appropriate use of treatments. There is increasing interest throughout the healthcare industry in optimizing and evaluating information by leveraging both existing internal and external methods and expertise. Industry trends and focus on patient centricity have led to an increase in the development of patient-facing content for general use and regulatory submission. In this workshop you will learn how to develop a consistent approach to optimizing medication information that objectively assesses these documents following evidence-based health literacy best practices. You will be walked through these recommendations in a step by step process with an industry use case. In addition, you will lean how to optimize information about medication and treatment to improve understandability and actionability while supporting adherence to company guidance on best practices involving patients, healthcare providers and subject matter experts.
Session Evaluation
4 Questions
4 Questions Once you have completed the session evaluation, please visit https://insthealthadv.wufoo.com/forms/q12p04ba0i09ye3/ to request your CEUs.